Susan G. Komen San Diego Hosts Third Annual Metastatic Breast Cancer Conference

On Saturday, January 25th, Susan G. Komen San Diego hosted its third annual Metastatic Breast Cancer Conference at the Hilton San Diego Bayfront.

Komen San Diego’s Metastatic Breast Cancer Conference brought together over 120 San Diegans living with metastatic breast cancer (stage IV or breast cancer that has spread to other parts of the body) and their loved ones, researchers, doctors, and more to learn about the latest innovations in treatments, clinical trials, and patient support from metastatic breast cancer experts.

Expert-led breakout sessions were done on holistic/complementary treatments, triple negative metastatic breast cancer, current available tools for treating metastatic breast cancer and what’s in the pipeline, palliative care, and metastatic by location: bones, lungs, brain and liver.

These breakout sessions were led by Dr. Rebecca Shatsky, MD, UC San Diego, Dr. Angelique Richardson, MD, PhD, UC San Diego Health, Dr. Sandra Dunn, PhD, Phoenix Molecular Design, Jennifer Moore Ballentine, MA, CSU Shiley Institute for Palliative Care, and Dr. Baljit Khamba, ND, Bastyr University.

Combating metastatic breast cancer is a top priority for Komen San Diego. Since its inception in 1995, Komen San Diego has invested over $19.6 million in cutting-edge research, with much of that investment staying locally in San Diego and focused specifically on metastatic breast cancer.

One woman a day dies from breast cancer in San Diego and Komen San Diego is tirelessly fighting every day to change this reality.